AI & ChatGPT searches , social queries for JTE 907
Search references for JTE 907. Phrases containing JTE 907
See searches and references containing JTE 907!
Search references for JTE 907. Phrases containing JTE 907
See searches and references containing JTE 907!JTE 907
Chemical compound
JTE-907 is a drug used in scientific research that acts as a selective CB2 inverse agonist. It has anti-inflammatory effects in animal studies, thought
JTE-907
Topics referred to by the same term
JTE may refer to: JTE Multimedia, a medical journal publishing company JTE-907, an anti-inflammatory drug Jahn–Teller effect, an effect which leads to
JTE
Psychoactive drug from the cannabis plant
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Cannabis_(drug)
Genus of flowering plants
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Cannabis
Species of plant
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Cannabis_ruderalis
Medication for pain and fever
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Paracetamol
Designer drugs
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Synthetic_cannabinoids
Specific cannabis extract
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Nabiximols
Plant species
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Cannabis_sativa
Chemical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Palmitoylethanolamide
Chemical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Monlunabant
Species of plant
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Cannabis_indica
Pharmaceutical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
ONO-1110
Pharmaceutical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Dronabinol/palmidrol
Chemical compound
CB1, with a Ki of 0.088nM at CB2 vs 11nM at CB1. JTE 7-31 is illegal in Alabama. A-834,735 JTE-907 MDA-19 N-(S)-Fenchyl-1-(2-morpholinoethyl)-7-meth
JTE_7-31
Phytocannabinoid discovered in 1940
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Cannabidiol
Phytocannabinoid
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Cannabidiorcol
HU-336 HU-345 HU-910 Ibipinabant, also known as 'SLV319' IDFP JNJ 1661010 JTE-907 JTE 7-31 JWH-007 JWH-015 JWH-018 JWH-019 JWH-030 JWH-051 JWH-073 JWH-081
List_of_cannabinoids
Species of plant
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Kava
Compounds found in cannabis
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Cannabinoid
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
MDMB-BINACA
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
MDMB-5'Br-BUTINACA
Chemical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Zevaquenabant
Protein-coding gene in the species Homo sapiens
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
ABHD12
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
ADB-5'F-BUTINACA
Japanese teletext standard
JTES, the Japanese Teletext Specification, is a protocol used for encoding Teletext pages, as well as other types of digital data, within the vertical
JTES
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Lixosicone
Chemical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
N-Arachidonylglycine
Chemical compound; modulator of the cannabinoid CB1 receptor
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
GAT100
Chemical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Oleoylethanolamide
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
AB-CHMINACA
Proposed mechanism of cannabis compounds
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Entourage_effect
Chemical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
2-Oleoylglycerol
Pharmaceutical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Irafamdastat
Homologue of tetrahydrocannabinol
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Tetrahydrocannabivarin
Psychoactive component of cannabis
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Tetrahydrocannabinol
Endocannabinoid reuptake inhibitor under development for psychiatric disorders
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
SYT-510
Pharmaceutical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Selonabant
Mammalian protein found in Homo sapiens
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Fatty-acid_amide_hydrolase_1
Biological system of neurotransmitters
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Endocannabinoid_system
Natural bicyclic sesquiterpene
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Caryophyllene
Minor cannabinoid
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Cannabigerol
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Endocannabinoid_transporter
Pharmaceutical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Tetrahydrocannabinol/cannabinol/cannabidiol
Tetrahydrocannabinol/cannabinol/cannabidiol
Class of enzymes
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Monoacylglycerol_lipase
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Cannabicyclohexanol
Chemical compound (fatty acid neurotransmitter)
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Anandamide
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
2-Arachidonyl_glyceryl_ether
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
AM-2201
Chemical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Docosatetraenoylethanolamide
Cannabis sativa L. (marijuana; hemp) used medicinally
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Medical_cannabis
Chemical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Stearoylethanolamide
Chemical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Yangonin
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
MDMB-CHMICA
Synthesis of THC from CBD
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Conversion_of_CBD_to_THC
Index of chemical compounds with the same molecular formula
C24H26N2O6 (molar mass: 438.473 g/mol, exact mass: 438.1791 u) may refer to: JTE-907 Suxibuzone This set index page lists chemical structure articles associated
C24H26N2O6
Chemical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Magnolol
Medication and supplement
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Pregnenolone_(medication)
Cannabinoid agonist compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Tetrahydrocannabiphorol
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
A-PONASA
Pharmaceutical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
EHP-102
Semi-sythetic cannabinoid drug
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Hexahydrocannabiphorol
Chemical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
4-O-Methylhonokiol
Pharmaceutical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Z8526711350
Pharmaceutical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Elcubragistat
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Rimonabant
Pharmaceutical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
WOBE437
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
AM-251_(drug)
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
CUMYL-3TMS-PRINACA
38-7271 BIM-018 CB-13 EG-018 EG-2201 FUBIMINA, BIM-2201, BZ-2201, FTHJ JTE-907 JTE 7-31 LY-2183240 MDA-19 MDMB-CHMCZCA, EGMB-CHMINACA NESS-0327 NESS-040C5
List_of_designer_drugs
Drug designed to treat obesity
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Orlistat
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
CUMYL-4CN-BINACA
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
JWH-007
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
THJ-018
Main secondary metabolite of THC
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
11-Nor-9-carboxy-THC
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
CUMYL-PEGACLONE
Active metabolite of Δ9-THC
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
11-Hydroxy-THC
Synthetic cannabinoid
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Nabilone
Working on the endocannabinoid neurotransmitters
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Cannabinoidergic
Phytocannabinoid compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Isotetrahydrocannabinol
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Etrinabdione
Synthetic cannabinoid, designer drug
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
ADB-5'Br-PINACA
Pharmaceutical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
CB-86
Chemical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Epicatechin_gallate
Chemical compound
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
Pregnenolone
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Cannabinodiol
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Ibipinabant
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Leelamine
Pharmaceutical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
VIP36
Mammalian protein found in Homo sapiens
JWH-015 JWH-133 L-759,633 L-759,656 Echinacea purpurea AM-630 BML-190 JTE-907 SR-144,528 APD371 Source: CNR1 GPR12 GPR6 S1PR1 S1PR4 S1PR3 S1PR5 S1PR2
Cannabinoid_receptor_2
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
BIA_10-2474
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Olorinab
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Pravadoline
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Tinabinol
Protein-coding gene in the species Homo sapiens
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
GPR55
Protein-coding gene in the species Homo sapiens
Virodhamine Antagonists 4-O-Methylhonokiol AM-630 BML-190 Cannabidiol Honokiol JTE-907 SR-144,528 WIN 54,461 WIN 56,098 NAGly (GPR18) Agonists Abnormal cannabidiol
ABHD6
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
JWH-133
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
5F-CUMYL-PEGACLONE
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
Methanandamide
Chemical compound
CE-178253 COR170 Drinabant (AVE1625) Hemopressin Ibipinabant (SLV319) JD-5037 JTE-907 LH-21 LY-320,135 MDA-77 MJ-15 MK-9470 Monlunabant MRL-650 NESS-0327 NIDA-41020
JWH-018
JTE 907
JTE 907
JTE 907
JTE 907
JTE 907
JTE 907
JTE 907
JTE 907
JTE 907